|
|
||||||||
American Journal of Clinical Nutrition, Vol 60, 129-135, Copyright © 1994 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
JC Witteman, DE Grobbee, FH Derkx, R Bouillon, AM de Bruijn and A Hofman
Department of Epidemiology, Erasmus University Medical School, Rotterdam, The Netherlands.
In a double-blind controlled trial, 91 middle-aged and elderly women with mild to moderate hypertension who were not on antihypertensive medication were randomly assigned to treatment with magnesium aspartate- HCl (20 mmol Mg/d) or placebo for 6 mo. Magnesium aspartate-HCl in the given dose was well-tolerated and was not associated with an increased frequency of diarrhea compared with placebo. At the end of the study, systolic blood pressure had fallen by 2.7 mm Hg (95% CI -1.2, 6.7; P = 0.18) and diastolic blood pressure by 3.4 mm Hg (1.3, 5.6; P = 0.003) more in the magnesium group than in the placebo group. Blood pressure response was not associated with baseline magnesium status, as measured by dietary magnesium intake and urinary magnesium excretion. Urinary magnesium excretion in the magnesium group increased by 50% during the intervention period. No changes were seen in other biochemical indexes, including serum concentrations of total and high-density-lipoprotein cholesterol. The findings suggest that oral supplementation with magnesium aspartate-HCl may lower blood pressure in subjects with mild to moderate hypertension.
This article has been cited by other articles:
![]() |
C. M. Champagne Magnesium in Hypertension, Cardiovascular Disease, Metabolic Syndrome, and Other Conditions: A Review Nutr Clin Pract, April 1, 2008; 23(2): 142 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Kotchen and D. A. McCarron Dietary Electrolytes and Blood Pressure : A Statement for Healthcare Professionals From the American Heart Association Nutrition Committee Circulation, August 11, 1998; 98(6): 613 - 617. [Full Text] [PDF] |
||||
![]() |
Y. Kawano, H. Matsuoka, S. Takishita, and T. Omae Effects of Magnesium Supplementation in Hypertensive Patients : Assessment by Office, Home, and Ambulatory Blood Pressures Hypertension, August 1, 1998; 32(2): 260 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Sacks, W. C. Willett, A. Smith, L. E. Brown, B. Rosner, and T. J. Moore Effect on Blood Pressure of Potassium, Calcium, and Magnesium in Women With Low Habitual Intake Hypertension, January 1, 1998; 31(1): 131 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Sacks, L. E. Brown, L. Appel, N. O. Borhani, D. Evans, and P. Whelton Combinations of Potassium, Calcium, and Magnesium Supplements in Hypertension Hypertension, December 1, 1995; 26(6): 950 - 956. [Abstract] [Full Text] |
||||
![]() |
J M Geleijnse, J C M Witteman, A A A Bak, J H den Breijen, and D E Grobbee Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension BMJ, August 13, 1994; 309(6952): 436 - 40. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |